Drug Patent Expirations in November 2010

Drug Patent Expirations in November 2010

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
SAMSCA Otsuka America Pharm tolvaptan 5,258,510 Nov 2, 2010
TRUVADA Gilead emtricitabine; tenofovir disoproxil fumarate 5,210,085*PED Nov 11, 2010
COZAAR Merck losartan potassium 5,210,079*PED Nov 11, 2010
EMTRIVA Gilead emtricitabine 5,210,085*PED Nov 11, 2010
ATRIPLA Gilead efavirenz; emtricitabine; tenofovir disoproxil fumarate 5,210,085*PED Nov 11, 2010
TAXOTERE Sanofi Aventis Us docetaxel 4,814,470*PED Nov 14, 2010
GEMZAR Lilly gemcitabine hydrochloride 4,808,614*PED Nov 15, 2010
RAPAMUNE Wyeth Pharms Inc sirolimus 5,212,155*PED Nov 18, 2010
FORTOVASE Hoffmann La Roche saquinavir 5,196,438 Nov 19, 2010
INVIRASE Hoffmann La Roche saquinavir mesylate 5,196,438 Nov 19, 2010
INVIRASE Roche saquinavir mesylate 5,196,438 Nov 19, 2010
VITRAVENE PRESERVATIVE FREE Novartis fomivirsen sodium 5,264,423 Nov 23, 2010
PEPCID AC Merck Sharp Dohme famotidine 5,075,114*PED Nov 23, 2010
PEPCID COMPLETE Merck Sharp Dohme calcium carbonate; famotidine; magnesium hydroxide 5,075,114*PED Nov 23, 2010
ADALAT CC Bayer Hlthcare nifedipine 5,264,446 Nov 23, 2010
PROCARDIA XL Pfizer nifedipine 5,264,446 Nov 23, 2010
ARICEPT ODT Eisai Inc donepezil hydrochloride 4,895,841 Nov 25, 2010
ARICEPT Eisai Inc donepezil hydrochloride 4,895,841 Nov 25, 2010
HYCAMTIN Smithkline Beecham topotecan hydrochloride 5,004,758*PED Nov 28, 2010
BUTRANS Purdue Pharma Lp buprenorphine 5,240,711 Nov 28, 2010

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com


Leave a Reply